VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2017 Update - Product Image

VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2017 Update

  • ID: 4372863
  • Company Profile
  • 66 pages
  • GlobalData
  • Volition RX
1 of 5

FEATURED COMPANIES

  • Ab Sciex Pte. Ltd.
  • Kino Biotech Co Ltd
  • PathGEN Dx Pte. Ltd.
  • SciGen Ltd
  • MORE
Summary

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company VolitionRX Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ab Sciex Pte. Ltd.
  • Kino Biotech Co Ltd
  • PathGEN Dx Pte. Ltd.
  • SciGen Ltd
  • MORE
  • VolitionRX Ltd Company Overview
  • VolitionRX Ltd Company Snapshot
  • VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • VolitionRX Ltd - Pipeline Analysis Overview
  • VolitionRX Ltd - Key Facts
  • VolitionRX Ltd - Major Products and Services
  • VolitionRX Ltd Pipeline Products by Development Stage
  • VolitionRX Ltd Ongoing Clinical Trials by Trial Status
  • VolitionRX Ltd Pipeline Products Overview
  • HyperGenomics Diagnostic Test - Colon Cancer
  • HyperGenomics Diagnostic Test - Colon Cancer Product Overview
  • HyperGenomics Diagnostic Test - Leukaemia
  • HyperGenomics Diagnostic Test - Leukaemia Product Overview
  • HyperGenomics Diagnostic Test - Prostate Cancer
  • HyperGenomics Diagnostic Test - Prostate Cancer Product Overview
  • Nu.Q CRC Screening Test
  • Nu.Q CRC Screening Test Product Overview
  • Nu.Q CRC Screening Test Clinical Trial
  • Nu.Q CRC Symptomatic Test
  • Nu.Q CRC Symptomatic Test Product Overview
  • Nu.Q CRC Triage Test
  • Nu.Q CRC Triage Test Product Overview
  • Nu.Q CRC Triage Test Clinical Trial
  • NuQ - A Androgen Receptor Cell Culture ELISA Kit
  • NuQ - A Androgen Receptor Cell Culture ELISA Kit Product Overview
  • NuQ - A EZH2 Cell Culture ELISA Kit
  • NuQ - A EZH2 Cell Culture ELISA Kit Product Overview
  • NuQ - A HMGB1 Cell Culture ELISA Kit
  • NuQ - A HMGB1 Cell Culture ELISA Kit Product Overview
  • NuQ - A Oestrogen Receptor Cell Culture ELISA Kit
  • NuQ - A Oestrogen Receptor Cell Culture ELISA Kit Product Overview
  • NuQ - A Progesterone Receptor Cell Culture ELISA Kit
  • NuQ - A Progesterone Receptor Cell Culture ELISA Kit Product Overview
  • NuQ - Prostate Cancer
  • NuQ - Prostate Cancer Product Overview
  • NuQ - Prostate Cancer Clinical Trial
  • NuQ - T001 Total Nucleosome ELISA Kit
  • NuQ - T001 Total Nucleosome ELISA Kit Product Overview
  • NuQ Diagnostic Test - Lung Cancer
  • NuQ Diagnostic Test - Lung Cancer Product Overview
  • NuQ Diagnostic Test - Lung Cancer Clinical Trial
  • NuQ Diagnostic Test - Pancreatic Cancer
  • NuQ Diagnostic Test - Pancreatic Cancer Product Overview
  • NuQ Diagnostic Test - Pancreatic Cancer Clinical Trial
  • NuQ Endo
  • NuQ Endo Product Overview
  • NuQ T003 Assay - Colorectal Cancer
  • NuQ T003 Assay - Colorectal Cancer Product Overview
  • NuQ V001 Assay - Colorectal Cancer
  • NuQ V001 Assay - Colorectal Cancer Product Overview
  • NuQ X001S Assay - Colorectal Cancer
  • NuQ X001S Assay - Colorectal Cancer Product Overview
  • NuQ X001S Assay - Colorectal Cancer Clinical Trial
  • NuQ-B
  • NuQ-B Product Overview
  • NuQ-IHC
  • NuQ-IHC Product Overview
  • NuQ-M Gamma - H2AX Cell Culture ELISA Kit
  • NuQ-M Gamma - H2AX Cell Culture ELISA Kit Product Overview
  • NuQ-M H3K27(Me)3 Cell Culture ELISA Kit
  • NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview
  • NuQ-M H4K16(Ac) Cell Culture ELISA Kit
  • NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview
  • NuQ-M H4K20(Me)3 Cell Culture ELISA Kit
  • NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview
  • NuQ-M H4Pan(Ac) Cell Culture ELISA Kit
  • NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview
  • NuQ-M Ubiquityl H2A Cell Culture ELISA Kit
  • NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview
  • NuQ-V
  • NuQ-V Product Overview
  • NuQ-V mH2A1.1 Cell Culture ELISA Kit
  • NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview
  • NuQ-V mH2A2 Cell Culture ELISA Kit
  • NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview
  • NuQ-X Hydroxymethylated DNA Cell Culture Kit
  • NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview
  • NuQ-X Methylated DNA Cell Culture Kit
  • NuQ-X Methylated DNA Cell Culture Kit Product Overview
  • VolitionRX Ltd - Key Competitors
  • VolitionRX Ltd - Key Employees
  • VolitionRX Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • VolitionRX Ltd, Recent Developments
  • Jun 30, 2017: Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress
  • Jun 27, 2017: VolitionRx Limited Corrects an Earlier Announcement
  • May 26, 2017: VolitionRx to Present at Multiple Investor Conferences in June
  • May 18, 2017: A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q assays
  • May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update
  • May 09, 2017: VolitionRx Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q Triage Test
  • Apr 27, 2017: Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe
  • Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer
  • Mar 20, 2017: VolitionRx Announces the Formation of Volition America
  • Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • VolitionRX Ltd Pipeline Products by Equipment Type
  • VolitionRX Ltd Pipeline Products by Indication
  • VolitionRX Ltd Ongoing Clinical Trials by Trial Status
  • VolitionRX Ltd, Key Facts
  • VolitionRX Ltd, Major Products and Services
  • VolitionRX Ltd Number of Pipeline Products by Development Stage
  • VolitionRX Ltd Pipeline Products Summary by Development Stage
  • VolitionRX Ltd Ongoing Clinical Trials by Trial Status
  • VolitionRX Ltd Ongoing Clinical Trials Summary
  • HyperGenomics Diagnostic Test - Colon Cancer - Product Status
  • HyperGenomics Diagnostic Test - Colon Cancer - Product Description
  • HyperGenomics Diagnostic Test - Leukaemia - Product Status
  • HyperGenomics Diagnostic Test - Leukaemia - Product Description
  • HyperGenomics Diagnostic Test - Prostate Cancer - Product Status
  • HyperGenomics Diagnostic Test - Prostate Cancer - Product Description
  • Nu.Q CRC Screening Test - Product Status
  • Nu.Q CRC Screening Test - Product Description
  • Nu.Q CRC Screening Test - Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer
  • Nu.Q CRC Symptomatic Test - Product Status
  • Nu.Q CRC Symptomatic Test - Product Description
  • Nu.Q CRC Triage Test - Product Status
  • Nu.Q CRC Triage Test - Product Description
  • Nu.Q CRC Triage Test - A Logistics and Pathway Design Study for Volition's CE Marked NuQ Triage Test in Screening Colorectal Cancer patients
  • NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Status
  • NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Description
  • NuQ - A EZH2 Cell Culture ELISA Kit - Product Status
  • NuQ - A EZH2 Cell Culture ELISA Kit - Product Description
  • NuQ - A HMGB1 Cell Culture ELISA Kit - Product Status
  • NuQ - A HMGB1 Cell Culture ELISA Kit - Product Description
  • NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Status
  • NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Description
  • NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Status
  • NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Description
  • NuQ - Prostate Cancer - Product Status
  • NuQ - Prostate Cancer - Product Description
  • NuQ - Prostate Cancer - A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer
  • NuQ - Prostate Cancer - Multicenter study to evaluate ability of NuQ to detect prostate cancer
  • NuQ - T001 Total Nucleosome ELISA Kit - Product Status
  • NuQ - T001 Total Nucleosome ELISA Kit - Product Description
  • NuQ Diagnostic Test - Lung Cancer - Product Status
  • NuQ Diagnostic Test - Lung Cancer - Product Description
  • NuQ Diagnostic Test - Lung Cancer - Detection of Lung Cancer with NuQ Blood Test
  • NuQ Diagnostic Test - Lung Cancer - Study to evaluate NuQ for early detection of 27 most prevalent cancers; and to evaluate differences in nucleosome structures between cancers
  • NuQ Diagnostic Test - Pancreatic Cancer - Product Status
  • NuQ Diagnostic Test - Pancreatic Cancer - Product Description
  • NuQ Diagnostic Test - Pancreatic Cancer - Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer
  • NuQ Endo - Product Status
  • NuQ Endo - Product Description
  • NuQ T003 Assay - Colorectal Cancer - Product Status
  • NuQ T003 Assay - Colorectal Cancer - Product Description
  • NuQ V001 Assay - Colorectal Cancer - Product Status
  • NuQ V001 Assay - Colorectal Cancer - Product Description
  • NuQ X001S Assay - Colorectal Cancer - Product Status
  • NuQ X001S Assay - Colorectal Cancer - Product Description
  • NuQ X001S Assay - Colorectal Cancer - Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study
  • NuQ-B - Product Status
  • NuQ-B - Product Description
  • NuQ-IHC - Product Status
  • NuQ-IHC - Product Description
  • NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Status
  • NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Description
  • NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Status
  • NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Description
  • NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Status
  • NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Description
  • NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Status
  • NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Description
  • NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Status
  • NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Description
  • NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Status
  • NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Description
  • NuQ-V - Product Status
  • NuQ-V - Product Description
  • NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Status
  • NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Description
  • NuQ-V mH2A2 Cell Culture ELISA Kit - Product Status
  • NuQ-V mH2A2 Cell Culture ELISA Kit - Product Description
  • NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Status
  • NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Description
  • NuQ-X Methylated DNA Cell Culture Kit - Product Status
  • NuQ-X Methylated DNA Cell Culture Kit - Product Description
  • VolitionRX Ltd, Key Employees
  • VolitionRX Ltd, Subsidiaries
  • Glossary
List of Figures
  • VolitionRX Ltd Pipeline Products by Equipment Type
  • VolitionRX Ltd Pipeline Products by Development Stage
  • VolitionRX Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • SciGen Ltd
  • PathGEN Dx Pte. Ltd.
  • Kino Biotech Co Ltd
  • Clearbridge BioLoc Pte Ltd
  • Ab Sciex Pte. Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll